Evercore ISI raises Blue Owl Capital stock price target on growth

Evercore ISI raised Blue Owl Capital's (NYSE:OWL) price target to $12.00 from $11.00, citing growth in direct lending and fee-paying assets. The stock trades at $10.41, with analysts seeing 22% upside. Blue Owl reported Q3 2026 earnings of $0.24 per share on $806.53M revenue, beating estimates, and increased AUM to $330B. The company maintains an 8.84% dividend yield and expects earnings growth in 2027.

Original reporting
Published Oct 30, 2026, 8:52 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 30, 2026, 8:59 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$OWL
Bullish
medium confidence
Mentioned
$OWL
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$OWLBullishMed
01

Why it matters

The price‑target increase may attract new buying interest, supporting short‑term price gains.

02

Market read

Analyst upgrade could drive modest buying pressure in the asset‑management space.

03

What to watch

Potential headwinds from rising interest rates affecting borrowing costs for leveraged loan portfolios.

Relevance 7/10Novelty 7/10Timing: immediate

Background

Evercore ISI's research note highlights Blue Owl Capital's strong direct‑lending performance and dividend yield.

Company-level read

Ticker impact

$OWLBullishMedium confidence
Context

Evercore ISI raised its price target on Blue Owl Capital to $12.00 from $11.00, indicating upside potential.

Expected impact

likely upward pressure as investors price in the higher target

Evidence & confidence

Target raise reflects belief the stock is undervalued and could rally on the new guidance.

Market effects

May boost sentiment in the asset‑management sector as peers could see similar target upgrades.

Primarily U.S. market effect; limited regional spillover.

Limited global impact beyond investors tracking U.S. listed asset managers.

Counterpoint

The target raise could be premature if fee growth slows or market conditions deteriorate.

Key entities

  • Blue Owl Capital

    Asset manager with growing direct‑lending business.

  • Evercore ISI

    Equity research boutique that issued the upgraded target.

Related articles

$OWLMed

Raymond James lowers Blue Owl Capital stock price target on slower wealth channel recovery

Raymond James cut its price target for Blue Owl Capital (NYSE: OWL) to $15 from $20, citing slower-than-expected recovery in wealth channel credit products. The firm adjusted EPS estimates, noting the stock trades at 11x next 12-month consensus EPS. Blue Owl reported Q3 2026 earnings of $0.24 per share, beating estimates, with revenue of $806.53 million and 12% AUM growth. Piper Sandler and Evercore ISI also raised their price targets.

$OWLMed

Piper Sandler raises Blue Owl Capital stock price target on results

Piper Sandler raised its price target for Blue Owl Capital (NYSE: OWL) to $13.00 from $12.00, citing strong results and increased earnings estimates. The company reported record fundraising, exceeding 2026 earnings forecasts, and shares rose 7%. Blue Owl's Q3 2026 earnings beat estimates, with a 15.54% revenue surprise and a 12% increase in assets under management to $330 billion.

$OWLMedAI 8/10

Blue Owl Capital Q3 Earnings Call Highlights

Blue Owl Capital reported $36B of AUM not yet earning fees, expected to generate $400M in annual fees. Credit fundraising totaled $5.6B, with real assets up 37%. Gross returns ranged from 6.4% to 13.4% across sectors. The company expects 2026 fee-related earnings to exceed $1.02 per share and anticipates margin expansion in 2027.

$OWLMed

OWL Stock Jumps As Sale Buzz And AI Deals Heat Up

Blue Owl Capital Inc. (NYSE: OWL) shares rose 6.74% on October 29, 2026, driven by potential sale discussions and AI-related deals. The stock has gained 16% in October, trading between $10.20 and $10.40. The company reported $2.87B in revenue, a 9.5% dividend yield, and $453M in quarterly free cash flow, but carries significant debt. Analysts have mixed price targets, with TD Cowen raising its target to $16.